RU2000106709A - GP41 PROTEIN EPITOPE PEPTIDES IMITATORS OF HUMAN IMMUNO DEFICIENCY VIRUS TYPE 1 RECOGNIZED BY 2F5 VIRAL NEUTRALIZING MONOCLONAL ANTIBODIES - Google Patents
GP41 PROTEIN EPITOPE PEPTIDES IMITATORS OF HUMAN IMMUNO DEFICIENCY VIRUS TYPE 1 RECOGNIZED BY 2F5 VIRAL NEUTRALIZING MONOCLONAL ANTIBODIESInfo
- Publication number
- RU2000106709A RU2000106709A RU2000106709/13A RU2000106709A RU2000106709A RU 2000106709 A RU2000106709 A RU 2000106709A RU 2000106709/13 A RU2000106709/13 A RU 2000106709/13A RU 2000106709 A RU2000106709 A RU 2000106709A RU 2000106709 A RU2000106709 A RU 2000106709A
- Authority
- RU
- Russia
- Prior art keywords
- monoclonal antibodies
- recognized
- imitators
- neutralizing monoclonal
- virus type
- Prior art date
Links
- 241000713772 Human immunodeficiency virus 1 Species 0.000 title claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 title claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 title claims 2
- 101150048348 GP41 gene Proteins 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
- 230000003612 virological effect Effects 0.000 title 1
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims 1
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 230000003278 mimic effect Effects 0.000 claims 1
Images
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2000106709/13A RU2179980C2 (en) | 2000-03-20 | 2000-03-20 | Peptide-simulator of human immunodeficiency type-1 virus protein gp41 conservative epitope recognized by virus-neutralizing monoclonal antibody 2f5 (variants) |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2000106709/13A RU2179980C2 (en) | 2000-03-20 | 2000-03-20 | Peptide-simulator of human immunodeficiency type-1 virus protein gp41 conservative epitope recognized by virus-neutralizing monoclonal antibody 2f5 (variants) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2000106709A true RU2000106709A (en) | 2002-01-27 |
| RU2179980C2 RU2179980C2 (en) | 2002-02-27 |
Family
ID=20232037
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2000106709/13A RU2179980C2 (en) | 2000-03-20 | 2000-03-20 | Peptide-simulator of human immunodeficiency type-1 virus protein gp41 conservative epitope recognized by virus-neutralizing monoclonal antibody 2f5 (variants) |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2179980C2 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100637981B1 (en) * | 2002-07-24 | 2006-10-23 | 에프. 호프만-라 로슈 아게 | PEGylated T20 Polypeptide |
| KR100630176B1 (en) * | 2002-07-24 | 2006-10-02 | 에프. 호프만-라 로슈 아게 | PEGylated T1249 Polypeptide |
| US7556813B2 (en) * | 2002-09-27 | 2009-07-07 | Trimeris, Inc. | Antiviral peptide-polymer conjugate comprising a polymer covalently attached to two or more synthetic HIV gp41 HR1 and/or HR2 peptides |
| EP2807181A1 (en) * | 2012-01-26 | 2014-12-03 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Vaccine compositions for hiv prevention and treatment |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5241047A (en) * | 1988-12-08 | 1993-08-31 | Biochem Pharma Inc. | Synthetic peptides and mixtures thereof for detecting HIV antibodies |
| WO1990007119A1 (en) * | 1988-12-20 | 1990-06-28 | Immunodiagnostics, Inc. | Synthetic hiv-like peptides, their compositions and uses |
| BR9406821A (en) * | 1993-06-09 | 1996-03-26 | Connaught Lab | Synthetic peptide immunogenic composition diagnostic kit useful for detecting HIV-specific antibodies in a test sample diagnostic kit for detecting HIV antigens in a test sample encoding nucleic acid molecule and antibody |
-
2000
- 2000-03-20 RU RU2000106709/13A patent/RU2179980C2/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200801798A1 (en) | VIROSOMOPROGABLE VESICULAS CONTAINING ANTIGENS DERIVED FROM GP41 | |
| ES2307496T4 (en) | HIV vaccine, antigen and peptide compositions | |
| WO2002020554A3 (en) | Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines | |
| DK1278534T3 (en) | Methods and compositions for attenuating the multiplication of HIV-1 | |
| ATE380822T1 (en) | FIVE-HELIX PROTEIN | |
| IL202249A (en) | Nucleic acids encoding modified human immunodeficiency virus type 1 (hiv-1) group m consensus envelope glycoproteins | |
| EA200300335A1 (en) | REGULATORY AND AUXILIARY HIV PEPTIDES, ANTIGENS, VACCINE COMPOSITIONS, SET FOR IMMUNO ANALYSIS AND METHOD OF DETECTING ANTIBODIES INDUCED BY HIV | |
| DK1417222T3 (en) | Isolated polypeptides based on the neutralizing epitope of the p17 protein from HIV suitable for vaccines as well as neutralizing anti-p17 antibodies that specifically recognize said neutralizing epitope | |
| NZ515356A (en) | Crystallised Fab'-epitope complex from the HIV-1 cross- neutralizing monoclonal antibody 2F5 | |
| RU2000106709A (en) | GP41 PROTEIN EPITOPE PEPTIDES IMITATORS OF HUMAN IMMUNO DEFICIENCY VIRUS TYPE 1 RECOGNIZED BY 2F5 VIRAL NEUTRALIZING MONOCLONAL ANTIBODIES | |
| RU2002126396A (en) | IMMUNOGENOUS CHIMER PEPTID LIBRARY MIMING THE GENETIC VARIETY OF HYPERVARIABLE DISTRICT V3 PROTEIN OF THE HUMAN IMMUNODEFICIENCY VIRUS GP120 | |
| ATE370160T1 (en) | PEPTIDES HAVING AFFINITY FOR GP120, AND USES THEREOF | |
| ATE343592T1 (en) | ANTIBODY DIRECTED AGAINST A PEPTIDE THAT MIMICS A CRYPTIC EPITOPE OF GP41 FROM HIV-1 | |
| Buratti et al. | Conformational display of two neutralizing epitopes of HIV-1 gp41 on the Flock House virus capsid protein | |
| Li et al. | Recombinant multi-epitope vaccine induce predefined epitope-specific antibodies against HIV-1 | |
| RU2000121342A (en) | GP120 HIV-1 PROTEIN EPITOP PEPTIDE SIMULATOR | |
| WO2002051865A3 (en) | Proteinic antigens inducing antibodies neutralising hiv virus | |
| WO2000058438A3 (en) | Conformationally constrained peptides | |
| Orlik et al. | Polyclonal bovine sera but not virus-neutralizing monoclonal antibodies block bovine leukemia virus (BLV) gp51 binding to recombinant BLV receptor BLVRcp1 | |
| FR2874017B1 (en) | MODIFIED HIV-1 PEPTIDES AND THEIR USE IN DETECTING ANTI-HIV ANTIBODIES | |
| DE69921589D1 (en) | Peptides for the detection of HIV-1-group O. | |
| EP1448984A4 (en) | Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens | |
| FR2839721B1 (en) | POLYPEPTIDE ANTIGEN INDUCING HIV NEUTRALIZING ANTIBODIES | |
| FR2818648B1 (en) | PROTEIN ANTIGENS INDUCING HIV VIRUS NEUTRALIZING ANTIBODIES | |
| TH62264A (en) | HIV peptides, vaccine constituents antigens, immunoassay kits. And a method for detecting antibodies induced by HIV |